AI assistant
Sending…
Actinium Pharmaceuticals, Inc. — Director's Dealing 2016
Jul 7, 2016
34570_dirs_2016-07-07_ba82dc8c-55ad-4104-b5ed-da384b8d4ca9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-07-05
Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-05 | Common Stock | S | 6000 | $1.82 | Disposed | 5001886 | Direct |
| 2016-07-05 | Common Stock | S | 4340 | $1.83 | Disposed | 4997546 | Direct |
| 2016-07-06 | Common Stock | S | 10500 | $1.8 | Disposed | 4987046 | Direct |
More from Actinium Pharmaceuticals, Inc.
Delisting Announcement
2026
May 29
Annual Report
2026
Mar 30
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 26
Board/Management Information
2026
Feb 13
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 26
Interim / Quarterly Report
2025
Nov 14
Annual Report
2025
Nov 5
Proxy Solicitation & Information Statement
2025
Nov 5
Director's Dealing
2025
Aug 20
Interim / Quarterly Report
2025
Aug 8